Molecular detection and subtype differentiation of avian influenza virus in mixed-species holdings

Introduction

Avian influenza virus (AIV) is a negative-sense, single-stranded, segmented RNA virus belonging to the family Orthomyxoviridae. The virus is classified into subtypes based on the antigenic properties of its surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA). Among the 16 HA subtypes (H1-H16) circulating in avian hosts, the H5 and H7 subtypes are of particular concern because they can evolve from low-pathogenicity avian influenza (LPAI) to highly pathogenic avian influenza (HPAI) forms through the acquisition of multiple basic amino acids at the HA cleavage site [1]. Mixed-species holdings, where ducks, geese, and chickens are housed in proximity, present unique diagnostic challenges. Waterfowl such as ducks and geese are natural reservoirs for AIV and often carry LPAI strains subclinically, while chickens are highly susceptible to HPAI strains, including H5N1 clade 2.3.4.4b [1]. The cohabitation of these species facilitates viral reassortment and complicates clinical surveillance, as LPAI infections in waterfowl may mask the early detection of HPAI incursions in chickens [2].

Molecular diagnostics have become the cornerstone of AIV detection and subtyping due to their high sensitivity, specificity, and rapid turnaround time. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) remains the gold standard for routine surveillance, while emerging technologies such as CRISPR-Cas12/13-based assays offer field-deployable alternatives for rapid subtype differentiation [1, 2]. This article provides an exhaustive technical review of the molecular principles, assay design considerations, and workflow integration for detecting and differentiating AIV subtypes in mixed-species poultry environments.

Biological and biophysical basis of AIV detection

Viral genome structure and target selection

The AIV genome comprises eight RNA segments (PB2, PB1, PA, HA, NP, NA, M, and NS). For molecular detection, the matrix (M) gene is the most conserved target across all AIV subtypes and is universally used for screening assays [1]. Subtype differentiation requires targeting the HA and NA genes. For H5N1, the HA gene segment (segment 4) contains the cleavage site sequence that distinguishes HPAI from LPAI. The HPAI phenotype is characterized by the presence of multiple basic amino acids (e.g., R-X-R/K-R) at the HA1-HA2 junction, which allows furin-like proteases in host cells to cleave the HA0 precursor into HA1 and HA2, enabling systemic viral replication [1]. In contrast, LPAI strains possess a single basic amino acid at the cleavage site, restricting cleavage to trypsin-like proteases found only in respiratory and intestinal epithelia.

In mixed-species holdings, the selection of primers and probes must account for sequence diversity across host-adapted strains. Ducks and geese may harbor distinct AIV lineages compared to chickens, and primer mismatches can lead to false-negative results [2]. Degenerate primers and locked nucleic acid (LNA) modifications are commonly employed to improve annealing efficiency across divergent templates.

RT-qPCR chemistry and thermal cycling physics

RT-qPCR combines reverse transcription of viral RNA into complementary DNA (cDNA) with subsequent PCR amplification and real-time fluorescence monitoring. The reaction relies on a thermostable DNA polymerase with reverse transcriptase activity or a separate reverse transcriptase enzyme. The biophysical principle involves the exponential amplification of target cDNA using sequence-specific primers and a hydrolysis probe (e.g., TaqMan) labeled with a fluorophore and a quencher. During the extension phase, the 5' to 3' exonuclease activity of the polymerase cleaves the probe, separating the fluorophore from the quencher and generating a fluorescence signal proportional to the amplicon concentration [1].

Thermal cycling parameters for AIV detection typically include a reverse transcription step at 50 degrees Celsius for 30 minutes, followed by initial denaturation at 95 degrees Celsius for 2 minutes, and 40 to 45 cycles of denaturation at 95 degrees Celsius for 15 seconds and annealing/extension at 55 to 60 degrees Celsius for 30 seconds. The annealing temperature must be optimized for each primer-probe set to ensure specificity, particularly when differentiating H5 from other HA subtypes [2].

RT-qPCR assay design for mixed-species holdings

Screening assay: M gene detection

The first-line screening assay targets the M gene, which is highly conserved across all AIV subtypes. A typical primer-probe set amplifies a 100-150 base pair region of the M1 protein coding sequence. The forward and reverse primers are designed to anneal to conserved regions, while the hydrolysis probe spans a highly conserved sequence to minimize the risk of mismatches [1]. The limit of detection (LOD) for M gene RT-qPCR is generally 10 to 100 RNA copies per reaction, depending on the assay design and the quality of the RNA extraction [2].

In mixed-species holdings, the M gene assay cannot differentiate between LPAI and HPAI strains. A positive M gene result must be followed by subtype-specific assays to determine the HA and NA subtypes and to assess pathogenicity.

Subtype differentiation: H5 and N1 detection

For H5N1 differentiation, the HA gene is targeted using primers and probes specific to the H5 subtype. The assay is designed to amplify a region spanning the HA cleavage site, allowing for sequence-based discrimination between LPAI and HPAI strains [1]. The HPAI H5 cleavage site motif (e.g., PQRERRRKR/GLF) contains multiple basic amino acids, while the LPAI motif (e.g., PQRE/TR/GLF) contains only one or two basic residues. RT-qPCR assays can be designed with two separate probes: one that detects the LPAI cleavage site and one that detects the HPAI cleavage site. Alternatively, a single probe targeting a conserved H5 region can be used, followed by Sanger sequencing of the amplicon to determine the cleavage site sequence [2].

The N1 neuraminidase gene is targeted using a separate primer-probe set. The N1 assay is essential for confirming the H5N1 subtype, as other H5 subtypes (e.g., H5N2, H5N8) may circulate in mixed-species holdings [1]. Multiplex RT-qPCR formats can simultaneously detect M gene, H5, and N1 targets in a single reaction, using fluorophores with distinct emission spectra (e.g., FAM, VIC, and Cy5) [2].

Internal control and inhibition monitoring

To prevent false-negative results due to PCR inhibition, an internal positive control (IPC) is included in each reaction. The IPC typically consists of an exogenous RNA template (e.g., a synthetic RNA or a heterologous viral RNA) that is amplified with a separate primer-probe set. The IPC is added to the master mix at a known concentration, and a shift in the cycle threshold (Ct) value of the IPC indicates the presence of inhibitors in the sample [1]. In mixed-species holdings, fecal and environmental samples often contain high levels of organic compounds (e.g., bile salts, polysaccharides) that can inhibit reverse transcription and PCR amplification. RNA extraction protocols that include a purification step using silica membrane columns or magnetic beads are recommended to remove inhibitors [2].

CRISPR-Cas12/13-based assays for field deployment

Mechanism of Cas12 and Cas13 nucleases

CRISPR-Cas systems have been adapted for nucleic acid detection by leveraging the collateral cleavage activity of Cas12 and Cas13 nucleases. Cas12 (previously known as Cpf1) is a DNA-targeting nuclease that, upon binding to its target DNA, non-specifically cleaves single-stranded DNA (ssDNA) reporters. Cas13 is an RNA-targeting nuclease that, upon binding to its target RNA, non-specifically cleaves single-stranded RNA (ssRNA) reporters [1]. For AIV detection, Cas13 is particularly useful because it directly targets viral RNA without requiring a reverse transcription step, although RT is often coupled to improve sensitivity.

The assay workflow begins with isothermal amplification of the target nucleic acid using recombinase polymerase amplification (RPA) or loop-mediated isothermal amplification (LAMP). The amplified product is then incubated with the Cas12 or Cas13 nuclease, a guide RNA (crRNA) complementary to the target sequence, and a quenched fluorescent reporter. Upon target recognition, the nuclease cleaves the reporter, generating a fluorescence signal that can be detected using a simple fluorometer or a lateral flow strip [2].

Application to H5N1 detection and LPAI differentiation

CRISPR-Cas13 assays have been developed for the detection of H5N1 AIV. The crRNA is designed to target a conserved region of the HA gene or the M gene. For subtype differentiation, multiple crRNAs can be used in a single reaction (multiplexing) or in parallel reactions. The collateral cleavage activity of Cas13 allows for the detection of attomolar concentrations of target RNA, making it comparable in sensitivity to RT-qPCR [1].

A key advantage of CRISPR-based assays for mixed-species holdings is their tolerance to sample impurities. Because the detection is based on enzymatic cleavage rather than thermal cycling, inhibitors that affect PCR have less impact on the reaction. Additionally, the isothermal nature of the amplification step (typically performed at 37 to 42 degrees Celsius) eliminates the need for expensive thermal cyclers, enabling point-of-care testing in field settings [2].

However, CRISPR-based assays have limitations. The specificity of the assay is dependent on the crRNA sequence, and mismatches in the target region can lead to false-negative results. For H5N1 differentiation, the crRNA must be designed to distinguish between HPAI and LPAI cleavage site sequences, which differ by only a few nucleotides. This requires careful bioinformatic analysis of circulating strains [1].

Workflow integration in mixed-species holdings

Sample collection and RNA extraction

In mixed-species holdings, sample collection must account for the different shedding patterns of ducks, geese, and chickens. Ducks and geese shed AIV primarily through the fecal route, while chickens shed virus through both respiratory and fecal routes [1]. Oropharyngeal and cloacal swabs are collected from individual birds and pooled by species for initial screening. Pooling reduces the cost of testing but decreases sensitivity if the prevalence is low. A maximum pool size of five swabs is recommended to maintain adequate detection [2].

RNA extraction is performed using commercial kits based on silica membrane technology or magnetic bead separation. The extracted RNA is eluted in a low-volume buffer (30-50 microliters) to maximize concentration. For environmental samples (e.g., feces, water, feed), a concentration step using polyethylene glycol precipitation or ultrafiltration may be necessary to recover viral particles [1].

Decision tree for molecular testing

The following Mermaid diagram illustrates the decision tree for molecular detection and subtype differentiation of AIV in mixed-species holdings.

flowchart TD
    A[Sample Collection: Oropharyngeal and cloacal swabs from ducks, geese, chickens], > B[RNA Extraction and Purification]
    B, > C[RT-qPCR M Gene Screening]
    C, Negative, > D[Report: No AIV Detected]
    C, Positive, > E[Multiplex RT-qPCR: H5 and N1 Subtyping]
    E, > F{H5 Positive?}
    F, No, > G[Report: LPAI Non-H5 Subtype]
    F, Yes, > H[HA Cleavage Site Sequencing or CRISPR-Cas13 Assay]
    H, > I{Multiple Basic Amino Acids at Cleavage Site?}
    I, Yes, > J[Report: HPAI H5N1]
    I, No, > K[Report: LPAI H5N1]
    J, > L[Initiate Quarantine and Notification]
    K, > M[Continue Surveillance]

Interpretation of results

A positive M gene result with a Ct value below 35 is considered a strong positive, while Ct values between 35 and 40 are considered weak positives and may require retesting [1]. For subtype differentiation, the H5 and N1 assays must have Ct values within 3 cycles of the M gene Ct value to confirm the subtype. If the H5 assay is positive but the N1 assay is negative, the sample may contain an H5 subtype other than H5N1 (e.g., H5N2) [2].

The HA cleavage site sequencing or CRISPR-Cas13 assay is used to determine pathogenicity. If the cleavage site contains multiple basic amino acids (e.g., RRRKKR), the strain is classified as HPAI. If the cleavage site contains only a single basic amino acid, the strain is classified as LPAI [1]. In mixed-species holdings, it is possible to detect both LPAI and HPAI strains in the same flock, particularly if waterfowl are carrying LPAI while chickens are infected with HPAI. In such cases, individual bird testing is necessary to determine the species-specific distribution of the virus [2].

Computational tools for assay design and surveillance

K-mer-based databases for primer design

The design of primers and crRNAs for AIV detection requires comprehensive sequence databases that capture the genetic diversity of circulating strains. K-mer-based databases, such as K-FluDB, enable rapid identification of conserved and variable regions across AIV genomes [2]. K-mers are short nucleotide sequences of length k (typically 20-30 nucleotides) that are used to index the genome. By comparing k-mer frequencies across thousands of AIV sequences, conserved regions suitable for primer binding can be identified, while variable regions can be targeted for subtype differentiation [2].

K-FluDB specifically facilitates the design of primers and probes for H5N1 detection by providing a searchable index of HA and NA sequences from diverse hosts, including ducks, geese, and chickens [2]. This resource is critical for ensuring that molecular assays remain effective as the virus evolves.

Genomic surveillance and variant calling

Ongoing genomic surveillance of AIV in mixed-species holdings is essential for detecting emerging variants that may escape molecular detection. Whole-genome sequencing of AIV isolates, followed by variant calling and phylogenetic analysis, allows for the identification of mutations in primer and probe binding sites [1]. If a mutation is detected in a conserved region, the assay must be redesigned to maintain sensitivity. The integration of computational pipelines for automated sequence analysis and alert generation is recommended for high-throughput surveillance programs [2].

Conclusion

Molecular detection and subtype differentiation of avian influenza virus in mixed-species holdings require a multi-tiered diagnostic approach. RT-qPCR targeting the M gene provides a sensitive screening tool, while subtype-specific assays for H5 and N1 enable differentiation of H5N1 from other subtypes. The HA cleavage site analysis, performed either by sequencing or by CRISPR-Cas13 assays, is essential for distinguishing HPAI from LPAI strains. The use of degenerate primers, internal controls, and robust RNA extraction protocols mitigates the challenges posed by sample impurities and sequence diversity. Computational tools such as K-FluDB support assay design and surveillance by providing up-to-date sequence databases. The integration of these molecular methods into a structured decision tree ensures accurate and timely diagnosis, facilitating effective outbreak control in complex poultry production systems.

References

[1] Srinivas S, Chothe SK, Ramasamy S, et al. Receptor basis of unusual tissue tropism of avian influenza H5N1 clade 2.3.4.4b virus in cattle. Sci Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42319934/

[2] Uscanga Junco A, Díaz-González L, Taboada B. K-FluDB: a novel K-mer-based database for enhanced genomic surveillance of Influenza A viruses. Bioinform Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42317557/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.